Literature DB >> 23794122

Osteomalacia induced by vitamin D deficiency in hemodialysis patients: the crucial role of vitamin D correction.

Fabrice Mac-Way1, Linda Azzouz, Christian Noel, Marie-Hélène Lafage-Proust.   

Abstract

Vitamin D deficiency/insufficiency is significantly prevalent in chronic kidney disease. Data in the literature are however scarce about the effects of this deficiency on bone metabolism in hemodialysis (HD) patients. Moreover, it is still debated whether low vitamin D levels should be normalized in HD patients. In this paper, we report two cases showing the deleterious consequences of vitamin D deficiency in HD patients which is characterised by hypophosphatemia, hypocalcemia and osteomalacia (OM) leading to bone fractures. As vitamin D repletion is an easy way to treat OM, this report underlines the importance of monitoring and correction of vitamin D deficiency in this population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23794122     DOI: 10.1007/s00774-013-0480-7

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  26 in total

Review 1.  Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies.

Authors:  Stefan Pilz; Simona Iodice; Armin Zittermann; William B Grant; Sara Gandini
Journal:  Am J Kidney Dis       Date:  2011-06-02       Impact factor: 8.860

2.  Vitamin D levels and early mortality among incident hemodialysis patients.

Authors:  Sébastien Mailliez; Irina Shahapuni; Caroline Lecaque; Ziad A Massy; Gabriel Choukroun; Albert Fournier
Journal:  Kidney Int       Date:  2008-08       Impact factor: 10.612

3.  Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?

Authors:  A Ghazali; P Fardellone; A Pruna; A Atik; J M Achard; R Oprisiu; M Brazier; A Remond; P Morinière; M Garabedian; J Eastwood; A Fournier
Journal:  Kidney Int       Date:  1999-06       Impact factor: 10.612

4.  Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis.

Authors:  Cs Ambrus; Cs Almasi; K Berta; Gy Deak; A Marton; M Zs Molnar; Zs Nemeth; Cs Horvath; P Lakatos; M Szathmari; I Mucsi
Journal:  Int Urol Nephrol       Date:  2010-03-18       Impact factor: 2.370

5.  Relationship between moderate to severe kidney disease and hip fracture in the United States.

Authors:  Thomas L Nickolas; Donald J McMahon; Elizabeth Shane
Journal:  J Am Soc Nephrol       Date:  2006-09-27       Impact factor: 10.121

6.  Vitamin D and kidney disease.

Authors:  Wisam Al-Badr; Kevin J Martin
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-01       Impact factor: 8.237

Review 7.  Chronic kidney disease and bone fracture: a growing concern.

Authors:  Thomas L Nickolas; Mary B Leonard; Elizabeth Shane
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

8.  [Hypophosphatemia in dialysis units].

Authors:  M Albalate; E Gruss; J Hernández; C Caramelo
Journal:  Nefrologia       Date:  2003       Impact factor: 2.033

9.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.

Authors:  Edward Giovannucci; Yan Liu; Bruce W Hollis; Eric B Rimm
Journal:  Arch Intern Med       Date:  2008-06-09

10.  Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.

Authors:  G Jean; J C Terrat; T Vanel; J M Hurot; C Lorriaux; B Mayor; C Chazot
Journal:  Nephron Clin Pract       Date:  2008-08-25
View more
  8 in total

1.  Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.

Authors:  A Amouzougan; A Deygat; B Trombert; E Constant; D Denarié; H Marotte; T Thomas
Journal:  Osteoporos Int       Date:  2015-06-24       Impact factor: 4.507

2.  Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.

Authors:  Rachel M Holden; Reem A Mustafa; R Todd Alexander; Marisa Battistella; Micheli U Bevilacqua; Greg Knoll; Fabrice Mac-Way; Martina Reslerova; Ron Wald; Philip D Acott; Patrick Feltmate; Allan Grill; Kailash K Jindal; Meena Karsanji; Bryce A Kiberd; Sara Mahdavi; Kailee McCarron; Amber O Molnar; Maury Pinsk; Celia Rodd; Steven D Soroka; Amanda J Vinson; Deborah Zimmerman; Catherine M Clase
Journal:  Can J Kidney Health Dis       Date:  2020-08-04

Review 3.  Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.

Authors:  Jordi Bover; Lucía Bailone; Víctor López-Báez; Silvia Benito; Paola Ciceri; Andrea Galassi; Mario Cozzolino
Journal:  J Nephrol       Date:  2017-04-21       Impact factor: 3.902

Review 4.  Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy.

Authors:  Sarah-Kim Bisson; Roth-Visal Ung; Fabrice Mac-Way
Journal:  Int J Endocrinol       Date:  2018-04-02       Impact factor: 3.257

5.  Osteomalacia and Vitamin D Status: A Clinical Update 2020.

Authors:  Salvatore Minisola; Luciano Colangelo; Jessica Pepe; Daniele Diacinti; Cristiana Cipriani; Sudhaker D Rao
Journal:  JBMR Plus       Date:  2020-12-21

6.  Treatment of Osteoporosis in Chronic Kidney Disease.

Authors:  Fellype Carvalho Barreto; Sérgio Gardano Elias Bucharles; Vanda Jorgetti
Journal:  J Bras Nefrol       Date:  2021-12-03

7.  Hidden Hypocalcemia as a Risk Factor for Cardiovascular Events and All-Cause Mortality among Patients Undergoing Incident Hemodialysis.

Authors:  Satoshi Yamaguchi; Takayuki Hamano; Yohei Doi; Tatsufumi Oka; Sachio Kajimoto; Keiichi Kubota; Seiichi Yasuda; Karin Shimada; Ayumi Matsumoto; Nobuhiro Hashimoto; Yusuke Sakaguchi; Isao Matsui; Yoshitaka Isaka
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

8.  Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis.

Authors:  Masaki Hatano; Izuru Kitajima; Seizo Yamamoto; Masaki Nakamura; Kazuya Isawa; Yutaka Hirota; Junichi Hoshino; Naoki Sawa; Yoshifumi Ubara
Journal:  BMC Nephrol       Date:  2021-09-03       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.